Latest Car T News

Page 12 of 29
Imugene Limited reports a narrower half-year loss as it advances its promising azer-cel CAR T therapy with strong clinical results and FDA backing, supported by a $25 million capital raise.
Ada Torres
Ada Torres
25 Feb 2026
McMillan Shakespeare Limited reported a 9.7% rise in statutory net profit for the first half of FY26, driven by strong revenue growth and productivity gains. The company declared a fully franked 62 cent dividend and announced a $10 million on-market share buyback.
Claire Turing
Claire Turing
23 Feb 2026
AdAlta Limited reported a $2.44 million loss for H1 FY26 while progressing a key CAR-T therapy collaboration and raising $2.8 million in capital. The company’s ‘East to West’ immunotherapy strategy gains momentum with regulatory tailwinds and cost efficiencies.
Ada Torres
Ada Torres
20 Feb 2026
Peter Warren Automotive Holdings reported a 3.2% revenue increase to $1.268 billion and more than doubled its profit after tax to $7.435 million in the first half of FY26, declaring a fully franked interim dividend of 3.0 cents per share.
Victor Sage
Victor Sage
20 Feb 2026
FSA Group Limited has reported a robust half-year performance with a 68% jump in profit before tax and declared a fully franked interim dividend of 3.5 cents per share. The company forecasts continued growth in 2026, targeting up to $40 million in annual profit.
Claire Turing
Claire Turing
19 Feb 2026
Arovella Therapeutics reported a 22% increase in half-year losses to $1.88 million while securing FDA acceptance of its IND application for lead asset ALA-101, paving the way for first-in-human trials.
Ada Torres
Ada Torres
19 Feb 2026
Autosports Group Limited reported a robust half-year with revenue rising 10.9% to $1.52 billion and profit after tax more than doubling to $21.68 million. The company declared a fully franked interim dividend of 5 cents per share, reflecting confidence in its growth trajectory.
Victor Sage
Victor Sage
19 Feb 2026
INOVIQ Limited reported a $3.96 million net loss for H1 2026, driven by increased R&D spend, while securing $10.2 million to accelerate its exosome-based cancer diagnostics and therapeutics pipeline.
Ada Torres
Ada Torres
18 Feb 2026
Jayride Group Limited reports a narrower quarterly loss amid revenue challenges, secures $200,000 through convertible notes, and inks a new SaaS agreement with Thailand’s Drivemate to expand its mobility platform.
Sophie Babbage
Sophie Babbage
17 Feb 2026
BHP Group Limited reported a robust half-year to December 2025, with copper overtaking iron ore as the top earnings contributor and a detailed technical assessment released for its promising Vicuña copper-gold project.
Maxwell Dee
Maxwell Dee
17 Feb 2026
Civmec Limited has reported a robust first half for FY26, with strong revenue growth, a record order book, and significant progress in naval shipbuilding. The company’s diversified operations and strategic contracts position it well for future growth.
Victor Sage
Victor Sage
13 Feb 2026
CAR Group Limited has reported a strong first half for FY26, posting 13% revenue growth and reaffirming its optimistic outlook for the full year, driven by strategic AI integration and global market expansion.
Sophie Babbage
Sophie Babbage
9 Feb 2026

Browse the archive

Full archive